
New Initiative to Boost H5N1 mRNA Vaccine Access in LMICs
By Ayomide Otitoju A new initiative to accelerate the development and accessibility of human avian influenza (H5N1) mRNA vaccine candidates for manufacturers in low- and middle-income countries (LMICs) was launched today in Switzerland. This effort will be spearheaded by Argentinian manufacturer Sinergium Biotech, leveraging the World Health Organization (WHO) and the Medicines Patent Pool (MPP)…